Elanco Animal Health Inc 8-K
Research Summary
AI-generated summary
Elanco Animal Health Files 8-K Reporting Financial Results (Feb 24, 2026)
What Happened Elanco Animal Health Inc. (ELAN) filed a Form 8-K with the SEC on February 24, 2026 reporting results of operations and financial condition. The company attached a press release dated February 24, 2026 as Exhibit 99.1 and incorporated that release by reference into Item 2.02. The filing includes an Inline XBRL cover page (104.1) and was signed by Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer.
Key Details
- Filing date: February 24, 2026.
- Item 2.02: Results of Operations and Financial Condition; disclosure made via press release (Exhibit 99.1).
- Exhibit 99.1: Press release issued by Elanco Animal Health Incorporated dated February 24, 2026.
- Interactive XBRL cover page included (Exhibit 104.1).
- Report signed by Robert M. VanHimbergen, EVP & CFO.
Why It Matters This 8-K notifies investors that Elanco has publicly released its operating and financial results (earnings/quarterly results) via a press release. The 8-K itself points to the press release for the actual revenue, profit, guidance or other financial metrics, so investors should review Exhibit 99.1 (or the company’s investor relations page / SEC EDGAR) to see the detailed numbers and any management commentary. The inclusion of XBRL makes the financial data machine-readable for analysts and tools that parse earnings information.